Balance Sheet Breakdown: Chimerix Inc (CMRX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

After finishing at $8.54 in the prior trading day, Chimerix Inc (NASDAQ: CMRX) closed at $8.55, up 0.12%. In other words, the price has increased by $0.12 from its previous closing price. On the day, 1.59 million shares were traded. CMRX stock price reached its highest trading level at $8.55 during the session, while it also had its lowest trading level at $8.53.

Ratios:

Our goal is to gain a better understanding of CMRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.69 and its Current Ratio is at 5.69. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 23, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.

On September 07, 2022, CapitalOne started tracking the stock assigning a Overweight rating and target price of $7.

On April 29, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $20.Maxim Group initiated its Buy rating on April 29, 2021, with a $20 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 13 ’25 when Melemed Allen S. sold 3,065 shares for $4.50 per share. The transaction valued at 13,799 led to the insider holds 152,875 shares of the business.

Andriole Michael T. sold 7,370 shares of CMRX for $33,282 on Feb 13 ’25. The PRESIDENT AND CEO now owns 609,603 shares after completing the transaction at $4.52 per share. On Feb 13 ’25, another insider, Alrutz Michael Albert, who serves as the SVP AND GENERAL COUNSEL of the company, sold 1,600 shares for $4.52 each. As a result, the insider received 7,226 and left with 213,596 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMRX now has a Market Capitalization of 802022528 and an Enterprise Value of 671556864. For the stock, the TTM Price-to-Sale (P/S) ratio is 3819.13 while its Price-to-Book (P/B) ratio in mrq is 6.48. Its current Enterprise Value per Revenue stands at 3167.721 whereas that against EBITDA is -6.961.

Stock Price History:

The Beta on a monthly basis for CMRX is -0.63, which has changed by 8.5 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, CMRX has reached a high of $8.55, while it has fallen to a 52-week low of $0.75. The 50-Day Moving Average of the stock is 23.16%, while the 200-Day Moving Average is calculated to be 198.37%.

Shares Statistics:

The stock has traded on average 4.04M shares per day over the past 3-months and 2413350 shares per day over the last 10 days, according to various share statistics. A total of 92.21M shares are outstanding, with a floating share count of 79.33M. Insiders hold about 15.43% of the company’s shares, while institutions hold 44.29% stake in the company. Shares short for CMRX as of 1743379200 were 3387024 with a Short Ratio of 0.84, compared to 1740700800 on 4732955. Therefore, it implies a Short% of Shares Outstanding of 3387024 and a Short% of Float of 3.81.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular